{
  "antimicrobial_resistance": {
    "definition": "The ability of microorganisms to resist the effects of antimicrobial agents",
    "es": "resistencia antimicrobiana",
    "fr": "résistance antimicrobienne",
    "pt": "resistência antimicrobiana",
    "context": "Primary concept in AMR surveillance",
    "source": "WHO terminology"
  },
  "minimum_inhibitory_concentration": {
    "definition": "The lowest concentration of an antimicrobial agent that inhibits visible growth of a microorganism",
    "es": "concentración inhibitoria mínima",
    "fr": "concentration minimale inhibitrice",
    "pt": "concentração inibitória mínima",
    "abbreviation": "MIC",
    "context": "Laboratory measurement standard",
    "source": "CLSI/EUCAST standards"
  },
  "susceptible": {
    "definition": "Clinical interpretation indicating the antimicrobial agent is likely to inhibit growth",
    "es": "sensible",
    "fr": "sensible",
    "pt": "sensível",
    "context": "Clinical interpretation category",
    "source": "Clinical breakpoint standards"
  },
  "intermediate": {
    "definition": "Clinical interpretation indicating antimicrobial activity in body sites with increased exposure",
    "es": "intermedio",
    "fr": "intermédiaire",
    "pt": "intermediário",
    "context": "Clinical interpretation category",
    "source": "Clinical breakpoint standards"
  },
  "resistant": {
    "definition": "Clinical interpretation indicating the antimicrobial agent is not likely to inhibit growth",
    "es": "resistente",
    "fr": "résistant",
    "pt": "resistente",
    "context": "Clinical interpretation category",
    "source": "Clinical breakpoint standards"
  },
  "breakpoint": {
    "definition": "MIC or zone diameter value that separates susceptible from non-susceptible categories",
    "es": "punto de corte",
    "fr": "seuil de sensibilité",
    "pt": "ponto de corte",
    "context": "Clinical interpretation threshold",
    "source": "CLSI/EUCAST guidelines"
  },
  "eucast": {
    "definition": "European Committee on Antimicrobial Susceptibility Testing",
    "es": "EUCAST",
    "fr": "EUCAST",
    "pt": "EUCAST",
    "context": "European clinical standards organization",
    "source": "Official acronym",
    "preserve_case": true
  },
  "clsi": {
    "definition": "Clinical and Laboratory Standards Institute",
    "es": "CLSI",
    "fr": "CLSI",
    "pt": "CLSI",
    "context": "US clinical standards organization",
    "source": "Official acronym",
    "preserve_case": true
  },
  "epidemiological_cutoff": {
    "definition": "MIC value that separates wild-type from non-wild-type populations",
    "es": "punto de corte epidemiológico",
    "fr": "seuil épidémiologique",
    "pt": "ponto de corte epidemiológico",
    "abbreviation": "ECOFF",
    "context": "Population-based resistance detection",
    "source": "EUCAST methodology"
  },
  "clinical_breakpoint": {
    "definition": "MIC value that defines clinical categories for treatment guidance",
    "es": "punto de corte clínico",
    "fr": "seuil clinique",
    "pt": "ponto de corte clínico",
    "context": "Treatment decision threshold",
    "source": "Clinical guidelines"
  },
  "quality_control": {
    "definition": "Procedures to ensure accuracy and reliability of antimicrobial susceptibility testing",
    "es": "control de calidad",
    "fr": "contrôle qualité",
    "pt": "controle de qualidade",
    "abbreviation": "QC",
    "context": "Laboratory quality assurance",
    "source": "Laboratory standards"
  },
  "antimicrobial_stewardship": {
    "definition": "Coordinated interventions to improve antimicrobial use",
    "es": "optimización del uso de antimicrobianos",
    "fr": "bon usage des antimicrobiens",
    "pt": "uso racional de antimicrobianos",
    "context": "Clinical practice optimization",
    "source": "WHO/CDC guidelines"
  },
  "surveillance": {
    "definition": "Systematic monitoring of antimicrobial resistance patterns",
    "es": "vigilancia",
    "fr": "surveillance",
    "pt": "vigilância",
    "context": "Public health monitoring",
    "source": "WHO GLASS methodology"
  },
  "pathogen": {
    "definition": "Disease-causing microorganism",
    "es": "patógeno",
    "fr": "pathogène",
    "pt": "patógeno",
    "context": "Infectious disease terminology",
    "source": "Medical terminology"
  },
  "nosocomial_infection": {
    "definition": "Healthcare-associated infection acquired in hospital setting",
    "es": "infección nosocomial",
    "fr": "infection nosocomiale",
    "pt": "infecção nosocomial",
    "context": "Hospital infection control",
    "source": "Healthcare terminology"
  },
  "multidrug_resistant": {
    "definition": "Resistant to multiple antimicrobial agent classes",
    "es": "multirresistente",
    "fr": "multirésistant",
    "pt": "multirresistente",
    "abbreviation": "MDR",
    "context": "Resistance phenotype classification",
    "source": "Clinical definitions"
  },
  "extensively_drug_resistant": {
    "definition": "Resistant to nearly all antimicrobial agent classes",
    "es": "extensamente resistente",
    "fr": "ultrarésistant",
    "pt": "extensivamente resistente",
    "abbreviation": "XDR",
    "context": "Severe resistance phenotype",
    "source": "Clinical definitions"
  },
  "pandrug_resistant": {
    "definition": "Resistant to all available antimicrobial agents",
    "es": "panresistente",
    "fr": "panrésistant",
    "pt": "panrresistente",
    "abbreviation": "PDR",
    "context": "Complete resistance phenotype",
    "source": "Clinical definitions"
  }
}
